Literature DB >> 12503691

Eosinophilic inflammation in sputum of poorly controlled asthmatics.

M Romagnoli1, I Vachier, P Tarodo de la Fuente, H Meziane, C Chavis, J Bousquet, P Godard, P Chanez.   

Abstract

Despite full effective treatment, asthmatic patients often present with poorly controlled asthma. Airway eosinophilia is associated with asthma, but its relationship with asthma control is still undetermined. To investigate the relationship between airway eosinophilia and asthma control, cellular and biochemical markers of airway inflammation were measured in 19 subjects with poorly controlled asthma, 16 subjects with asthma under control and eight normal volunteers. The severity of asthma was mild-to-moderate persistent in 23 patients (14 poorly controlled) and severe prednisone-dependent in 12 subjects (five poorly controlled). Induced sputum was analysed for total and differential cell counts, leukotriene E4 (LTE4), eosinophil cationic protein (ECP), regulated on activation, normal T-cell expressed and secreted (RANTES), and interleukin (IL)-8. Sputum eosinophils, LTE4, ECP and RANTES levels (but not IL-8) were significantly higher in patients with poorly controlled asthma as compared to patients with controlled asthma. By contrast, sputum cells and sputum inflammatory markers were not different among groups of patients with different severity of asthma. These results suggest that sputum eosinophilia is associated with poorly controlled asthma rather than with the severity of asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503691     DOI: 10.1183/09031936.02.00029202

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X.

Authors:  Ying Lai; Rob C Oslund; James G Bollinger; William R Henderson; Luis F Santana; William A Altemeier; Michael H Gelb; Teal S Hallstrand
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils.

Authors:  Teal S Hallstrand; Ying Lai; Kathryn A Hooper; Rob C Oslund; William A Altemeier; Gustavo Matute-Bello; Michael H Gelb
Journal:  J Allergy Clin Immunol       Date:  2015-06-30       Impact factor: 10.793

3.  Relationship between levels of secreted phospholipase A₂ groups IIA and X in the airways and asthma severity.

Authors:  T S Hallstrand; Y Lai; Z Ni; R C Oslund; W R Henderson; M H Gelb; S E Wenzel
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

4.  Decreased T-bet expression and changes in chemokine levels in adults with asthma.

Authors:  F W S Ko; S W M Lun; C K Wong; C C Szeto; C W K Lam; T F Leung; D S C Hui
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

Review 6.  Effects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysis.

Authors:  Thiago Mamôru Sakae; Rosemeri Maurici; Daisson José Trevisol; Marcia Margaret Menezes Pizzichini; Emílio Pizzichini
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 7.  Management of the patient with eosinophilic asthma: a new era begins.

Authors:  Jantina C de Groot; Anneke Ten Brinke; Elisabeth H D Bel
Journal:  ERJ Open Res       Date:  2015-09-23

8.  Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Authors:  Marie-Chantal Larose; Anne-Sophie Archambault; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  Front Med (Lausanne)       Date:  2017-08-11

9.  Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation.

Authors:  Florence N Schleich; Maité Manise; Jocelyne Sele; Monique Henket; Laurence Seidel; Renaud Louis
Journal:  BMC Pulm Med       Date:  2013-02-26       Impact factor: 3.317

Review 10.  Airway disease: similarities and differences between asthma, COPD and bronchiectasis.

Authors:  Rodrigo Athanazio
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.